Daniel Faga insider trades
Open-market stock purchases and sales by Daniel Faga, President, CEO at First Tracks Biotherapeutics, Inc, from SEC Form 4 filings since May 2, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 15, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 2, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
| Apr 20, 2026 | ANAB Anaptysbio, Inc | Sold (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc | Bought (not open market) | — |